Skip to main content

Emma Parmee

Global Head Therapeutics Discovery at The Janssen Pharmaceutical Companies of Johnson & Johnson

As Global Head of Therapeutics Discovery within Janssen Research & Development, Emma Parmee is currently responsible for execution of the discovery portfolio and delivery of development candidates across all therapeutic modalities including small molecules, biologics, peptides, and RNA, gene, and cell therapies.


Emma joined Janssen in November 2020 following a 28-year career at Merck Research Labs (MRL), most recently serving as Head of Discovery Chemistry. Emma obtained her D. Phil. Degree in 1990 at the University of Oxford and then completed a NATO postdoctoral fellowship at MIT.


Among other awards, Emma was the recipient of the 2018 ACS Medicinal Chemistry Division Award and was inducted into the ACS MEDI Hall of Fame in 2018.  In 2022, Emma received an Arthur C. Cope Scholar award from the ACS. Her work has led to more than 40 issued US patents and more than 50 publications in peer-reviewed journals.